Sublingual Methadone for the Management of Cancer Breakthrough Pain
Clinical trial NCT00125294 · COMPLETED
Trial details
- NCT number
- NCT00125294
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2006-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.